Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has received an order from the Assessment Unit of the Income Tax Department imposing a penalty of ₹11,33,130. The penalty is related to transactions with employees and vendors that were adjusted through journal entries against past debit/credit entries, which the IT Department classified as loans or deposits. The company states that other than the penalty amount, there is no impact on its financial or operational activities. Max Healthcare is in the process of filing an appeal against this order.

Max Healthcare Institute Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from Wednesday, July 1, 2026, and will remain in effect for 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The date of the board meeting to approve these financial results will be communicated separately. The disclosure will also be available on the company's website.

The Competition Commission of India (CCI) has passed orders in favor of Max Healthcare's network hospitals, stating that no case of abuse of dominant position under Section 4 of the Competition Act, 2002 is established. This follows earlier intimations and a re-investigation directed by the CCI in 2018. The CCI rejected the Director General's findings after considering supplementary reports, hospital objections, and submissions. The orders, received on May 21, 2026, are available on the CCI website.

Max Healthcare Institute Ltd's board approved the construction of Phase-I of Max Super Specialty Hospital in Lucknow on a 5-acre land parcel owned by the company. The hospital will have a capacity of approximately 712 beds. The board also approved the audited financial results for FY26, recommended a final dividend of ₹2 per equity share, re-appointed cost auditors, approved the re-classification of Radiant Life Care Hospital Foundation, approved shifting of registered office and re-appointed Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director.

Max Healthcare Institute Ltd's board re-appointed Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director for three years, effective October 1, 2026, subject to member approval. The board also approved the audited financial results for FY26, recommended a final dividend of ₹2 per share, re-appointed cost auditors, approved the re-classification of Radiant Life Care Hospital Foundation, approved construction of a hospital in Lucknow, and approved shifting the registered office to Haryana.

Max Healthcare Institute Ltd's board approved the re-classification of Radiant Life Care Hospital Foundation from the 'Promoter Group' to the 'Public' category, subject to stock exchange approvals. The board also approved the construction of Phase-I of Max Super Specialty Hospital in Lucknow and the shifting of the registered office to Gurugram, Haryana, pending member and regulatory approvals. Additionally, a final dividend of ₹2 per equity share was recommended, and the re-appointment of cost auditors and a non-executive director were approved.

Max Healthcare Institute Ltd's board re-appointed M/s. Chandra Wadhwa & Co. as Cost Auditors for the financial year 2026-27, following the recommendation of the Audit Committee. The board also approved the audited financial results for FY26, recommended a final dividend of ₹2 per share, approved the re-classification of Radiant Life Care Hospital Foundation, approved construction of a new hospital in Lucknow and the shifting of the registered office to Gurugram, Haryana.

Max Healthcare Institute Ltd's board approved shifting the registered office from Maharashtra to Haryana, subject to member and regulatory approvals. The board also approved the audited financial results for FY26, recommended a final dividend of ₹2 per share, re-appointed cost auditors, approved the re-classification of Radiant Life Care Hospital Foundation, approved construction of Phase-I of Max Super Specialty Hospital, Lucknow and re-appointed Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director.

Max Healthcare Institute Ltd's board approved the audited financial results for FY26 and recommended a final dividend of ₹2 per equity share. They also approved the re-appointment of cost auditors, the re-classification of Radiant Life Care Hospital Foundation, construction of a hospital in Lucknow, shifting of the registered office, and the re-appointment of a non-executive director.

Max Healthcare Institute Ltd announced its Q4 FY26 results, with revenue rising to ₹2,664 Cr, a 10% YoY increase. Network operating EBITDA grew by 8% YoY to ₹682 Cr, while Q4 PAT increased to ₹387 Cr. The company commissioned additional brownfield capacity and acquired a controlling stake in Kalinga Hospital Ltd. The board approved an investment of ₹1,400 Cr for a new greenfield hospital in Lucknow.